AEON Biopharma (AEON)

• Market cap: $27.9M
• 1 day: -2.52%
• 5 days: 5.45%
• 1 month: 7.41%
• 3 months: 37.44%
• 6 months: 57.87%
• Year to date: 4.5%
• 1 year: -86.74%
• 5 years: -99.83%
• 10 years: -99.83%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Employees: 5